Single subject — no qualification is awarded on completion. Credits toward the qualifications listed below.
This subject is FEE-HELP eligible, so eligible students can defer the $2,862 fee as a government loan and pay nothing upfront.
Fees and funding are indicative only. Confirm your eligibility and final costs with the provider.
A student visa requires a full-time CRICOS-registered course, and single subjects have no CRICOS registration. If you’re studying in Australia on a student visa, you’ll need a full qualification instead.
See CRICOS-registered alternativesThis fully online subject provides you with the knowledge and skills to improve medication safety. The subject introduces you to medication-related problems, along with current practices to reduce these problems in Australian health care. It is contextualised to align with the Australian response to the global challenge of reducing medication-related harm. This subject equips you to play an important role within a model of collaborative interprofessional teamwork.
Quality Use of Medicines and Medicines Safety in Vulnerable Populations is a standalone subject at University of Tasmania in TAS. Completing it does not award a qualification. Credit may apply toward the qualifications listed on this page.
No qualification credit mapping has been indexed for this subject yet. The provider may still grant credit toward a related award — confirm with University of Tasmania before enrolling.
University of Tasmania is the awarding provider. Recorded study modes are Online. Typical duration is listed as 12 weeks. The subject is listed at 25 credit points. Eligible students may defer fees through FEE-HELP.
Details on this page are compiled from the provider's published subject information and government registers. Fees, intakes and credit rules can change — confirm current details with University of Tasmania before enrolling.
